WrapManager Inc’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,643
Closed -$304K 292
2022
Q3
$304K Sell
5,643
-416
-7% -$21.4K 0.1% 198
2022
Q2
$244K Sell
6,059
-121
-2% -$6K 0.08% 243
2022
Q1
$409K Buy
6,180
+182
+3% +$12.5K 0.11% 180
2021
Q4
$600K Sell
5,998
-517
-8% -$53.5K 0.15% 141
2021
Q3
$814K Sell
6,515
-93
-1% -$11.1K 0.21% 105
2021
Q2
$821K Buy
6,608
+1,078
+19% +$145K 0.21% 101
2021
Q1
$844K Sell
5,530
-87
-2% -$13.1K 0.23% 96
2020
Q4
$724K Sell
5,617
-65
-1% -$7.48K 0.21% 101
2020
Q3
$635K Sell
5,682
-90
-2% -$8.23K 0.21% 103
2020
Q2
$468K Sell
5,772
-607
-10% -$48.9K 0.17% 142
2020
Q1
$444K Buy
+6,379
New +$490K 0.2% 119

Other funds holding GH

WrapManager Inc's GH Position: Q4 2022 in Review

WrapManager Inc sold out of Guardant Health (GH) in Q4 2022, closing a stake of 5,643 shares — an estimated $304K sold.

WrapManager Inc first reported a position in GH in Q1 2020 and held it in 11 quarters. The position peaked at $844K in Q1 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • WrapManager Inc reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • WrapManager Inc sold 5,643 Guardant Health shares in Q4 2022, an estimated $304K.
  • WrapManager Inc first reported a position in Guardant Health in Q1 2020 and held it in 11 quarters.
  • WrapManager Inc's Guardant Health position peaked at $844K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on WrapManager Inc's 13F filing for Q4 2022, filed 6 Feb 2023.